Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to johnstevens77,Bhoddhisatva,scotia,Anonymous,Cornytiv34, for Donating to support the site

MrC's Smallcap Sweeps for Jan 2022

Discuss Stock buying Shares, tips and ideas for stock market dealing
MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

MrC's Smallcap Sweeps for Jan 2022

#470064

Postby MrContrarian » January 4th, 2022, 7:42 am

Smallcap Sweep. 04-Jan-22
2022. What fresh hell is this?

Chamberlin (CMH) £0.8m order for components used in the construction of a major London based infrastructure project. Will complete in calendar 2022. [SP=7.29 Cap=5m]
Sportech (SPO) completes sale of share of Leidsa contract fr $12.5m + $2m max in royalties. [SP=37.6 Cap=38m]
Avation (AVAP) Philippine Airlines has exited bankruptcy and will continue to lease AVAP's 777. From March the lease payments will revert to a fixed market rate rent along with cash maintenance reserves. [SP=89 Cap=61m]
Tasty (TAST) H2(Dec) was extremely encouraging until December which was considerably weaker than expected. Co "optimistic about the trading potential of the Group, especially with the strong revenue stream provided by takeaway and delivery services." [SP=5.25 Cap=7m]
Macfarlane (MACF) sells Macfarlane Labels for £6.4m, "which will broadly align with net asset value". Below NAV then. FY20 pretax was £0.3m. [SP=130 Cap=205m]
Chill Brands (CHLL) recruits a sales director from leading vape brand Juul as CCO. Why would he leave a $2bn rev co for this POS? [SP=15.75 Cap=33m]
DX (DX.) suspended as expected due to delay to AR. [SP=30 Cap=172m]
Edita Food Industries (EFID) acquisition of the Ole maker for croissant, cakes is off. [SP=NA Cap=NA]
SigmaRoc (SRC) buys Johnston Quarry and Guiting Quarry for £35.5m. Also conditionally agreed to buy 2 more quarries from sellers for a total potential sum of £14.5m. [SP=85 Cap=533m]
Renalytix (RENX) joint program with the American Diabetes Association to improve overall kidney health in patients with type 2 diabetes. Aims to drive early detection and risk-informed care delivery. [SP=600.8 Cap=590m]
LungLife AI (LLAI) makes first step on the path for commercial reimbursement as it gets US CPT code for LungLB test. [SP=185 Cap=NA]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#470366

Postby MrContrarian » January 5th, 2022, 7:29 am

Smallcap Sweep. 05-Jan-22
Incomplete investment insights

Blue Star Capital (BLU) not aware of a reason for 38% SP rise yesterday [SP=0.51 Cap=25m]
Shield Therapeutics (STX) licence agreement with KYE Pharmaceuticals for development and commercialisation of Accrufer. Up to £1m pyments to STX. [SP=47 Cap=101m]
MyHealthChecked (MHC) partnership with Lloyds Pharmacy for covid pre-travel testing. [SP=2.33 Cap=18m]
Verici Dx (VRCI) collaboration with US co Illumina "to expedite the operational launch of data analysis processing and predictive artificial intelligence component of Verici Dx's products using early access to ICA, Illumina's new software platform for operationalized secondary analysis with an advanced data science environment". Uses transcriptomic analysis natch'. [SP=55.25 Cap=79m]
Concurrent Technologies (CNC) guides FY(Dec) rev and profit slightly ahead of market expectations. "Whilst the component issues are ongoing, the Company enters 2022 with a robust order book and an exciting pipeline of innovative product releases to grow our customer base and revenues." [SP=79 Cap=58m]
OptiBiotix (OPTI) gets British Retail Consortium food safety accreditation. It's accepted by many retailers, such as Tesco and Walmart. [SP=45.88 Cap=40m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#470710

Postby MrContrarian » January 6th, 2022, 7:33 am

Smallcap Sweep. 06-Jan-22
Palpating the abdomen of announcements

MGC Pharmaceuticals (MXC) Indian Regulators approve ArtemiC Rescue, a clinically tested food supplement that improves covid recovery. [SP=2.14 Cap=105m]
M&C Saatchi (SAA) director Vin Murria makes approach. "No proposal has been received but the Board has been told to expect one in the near term." [SP=189 Cap=231m]
SRT Marine Systems (SRT) formal written notice of award of first phase of a system contract worth £40m over all phases. Formal contract signing by end Jan. [SP=43 Cap=71m]
Made.com (MADE) guides FY(Dec) rev up 38%, in line. [SP=140.2 Cap=547m]
Ridgecrest (RDGC) will de-list on & Jan due to not making an RTO. [SP=1.1 Cap=5m]
Digitalbox (DBOX) guides FY(Dec) significantly ahead of the recently upgraded market consensus of EBITDA of £850k. Rev now expected to be £3.6m+. [SP=9.45 Cap=11m]
Ten Entertainment (TEG) guides FY(Dec) profit at the top end of expectations. [SP=252 Cap=172m]

In line: MTW, SOS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#471057

Postby MrContrarian » January 7th, 2022, 7:28 am

Smallcap Sweep. 07-Jan-22
Desoldering the joints of RNS Radio

Air Partner (AIR) guides FY(Jan) U/L pretax materially ahead of market expectations due to high levels of Freight bookings, especially of vaccines. [SP=86 Cap=55m]
Judges Scientific (JDG) guides FY(Dec) adj EPS ahead of market expectations of 209.7p. Organic order intake up 8.5% against 2019. [SP=8180 Cap=517m]
Churchill China (CHH) guides FY(Dec) pretax in line. "The necessity to scale production quickly in order to meet increased demand has created additional pressure on our operations alongside cost inflation, leading to some inefficiencies within our manufacturing unit. We expect these effects to continue into 2022, but to show progressive improvement over the year as a whole. We believe that profitability in 2022 will show further substantial growth on 2021's outfall." [SP=1703 Cap=188m]
Lookers (LOOK) guides FY(Dec) U/L pretax above market consensus of £82m. Outlook "starting 2022 with an excellent new car order bank. However, given ongoing global supply chain disruptions, uncertainty as to the availability of new vehicles and the sustainability of used car margins at current levels, the Board believes it is right to remain cautious". [SP=70 Cap=274m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#471665

Postby MrContrarian » January 10th, 2022, 7:51 am

Smallcap Sweep. 10-Jan-22
Tripping on intoxicating optimism

Avacta (AVCT) withdraws its covid LFT since it has lower sensitivity to Omicron at lower viral loads, as do other LFTs. It will replace the antibody in the test to improve performance. [SP=115 Cap=292m]
Electra Private Equity (ELTA) Hotter Shoes "continued to deliver strong growth during November and December, with revenues being +9%." [SP=68 Cap=26m]
Dekel Agri-Vision (DKL) FY(Dec) production: Dec CPO production up 110% and record price of CPO price of €968/T. [SP=5.2 Cap=28m]
Renalytix (RENX) partnership with Singing River Health System to deploy KidneyIntelX informed care management to improve kidney health in individuals with type 2 diabetes and early-stage chronic kidney disease. Singing River has locations across the Mississippi Gulf Coast. [SP=545 Cap=532m]
Nightcap (NGHT) guides H1(Dec) rev up 46% on 2019 and LFL up 22%. In line? [SP=19.35 Cap=37m]
Audioboom (BOOM) guides FY(Dec) maiden net profit c.$1.4m, Adj EBITDA ahead of market expectations. [SP=1410 Cap=223m]
Venture Life (VLG) has appointed a new Chinese partner for two of VLG's leading oral care brands after terminating the previous partner due to poor sales. [SP=39 Cap=49m]
Tortilla Mexican Grill (MEX) guides FY(Jan) LFL up 24%. Rev and profit materially ahead of mgmt expectations. Guides This FY in line. [SP=182.25 Cap=71m]
Quartix Technologies (QTX) guides FY(Dec) rev and FCF at £25.6m and £3.8m, in line, but adj EBITDA substantially ahead at £5.7m (F/C £5m). [SP=400 Cap=194m]
Gresham House Energy Storage Fund (GRID) guides FY(Dec) comfortably ahead of modelled levels and EBITDA of the asset portfolio over £40m. Guides FY22 NAV growth towards the upper end of the target range of 8% to 15%. [SP=132.7 Cap=576m]
Microsaic Systems (MSYS) guides FY(Dec) rev £0.90m cf FY20's terrible £0.2m and FY10 £0.87m. In line? "Backlog of orders remaining from 2021 will be shipped in early FY22, which mainly reflects global supply chain pressures resulting from COVID-19. The Company is working hard to mitigate disruption to its key supply chain such that any future impact will continue to be minimal." [SP=0.18 Cap=11m]
Cambridge Cognition (COG) £700k contact over 2 yrs for schizophrenia trials. [SP=124.25 Cap=38m]
Toople (TOOP) 3 yr contract to supply 46 hosted voice seats to the UK's leading horse feed supplier. That's chicken feed. [SP=0.05 Cap=3m]
Frenkel Topping (FEN) £5m + £5m earn-out acquisition. Guides FY(Dec) in line. [SP=77 Cap=89m]

In line: MRK
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#471931

Postby MrContrarian » January 11th, 2022, 7:44 am

Smallcap Sweep. 11-Jan-22
Trading triage in the City clinic

Gresham Technologies (GHT) guides FY(Dec) rev up 95%, adj EBITDA up 58%, ahead of market expectations. [SP=169 Cap=141m]
DeepVerge (DVRG) guides FY21 rev up 108%. Supply chain delays and staff self isolation delayed some shipments to FY22. Pretax loss £2.87m. "While the losses may exceed market expectations, it is primarily due to delayed execution of 2021 orders." May exceed? [SP=23 Cap=49m]
Vianet (VNET) wins 'significant' 3 yr contract for Smart Machines Division from Lavazza Professional UK. No material impact this FY. No £££. [SP=98 Cap=28m]
Diaceutics (DXRX) guides FY(Dec) rev £13.9m up 10% and 17% in const currency. Adj EBITDA up 294% to £2.1m, in line. [SP=102 Cap=86m]
Robert Walters (RWA) guides Q4(Dec) rev up 33%. FY net fee income up 21%, profit comfortably ahead of expectations (whose?). [SP=811.92 Cap=622m]
SIG (SHI) guides FY(Dec) rev up 24%. U/L op profit £40m+, as guided. Outlook "confident that the momentum built in 2021 will continue in 2022 and, providing there is no material disruption to either our business or end markets, expects the Group to deliver solid organic revenue growth in the coming year". [SP=46.56 Cap=550m]
Deltex Medical (DEMG) guides FY(Dec) rev £2.3m (£2.4m). "Although the Group's direct business in the USA and the UK has not yet returned to pre-pandemic levels, the performance of the International division significantly improved during the year. The backlog in elective surgical cases continues to build around the world." Cash at hand only £0.4m. [SP=1.39 Cap=8m]
Bango (BGO) guides FY(Dec) rev up 32%, ahead of exp. Adj EBITDA in line. [SP=195 Cap=148m]
Franchise Brands (FRAN) FY(Dec) trading.'strong'. Metro Rod hits £50m of system sales, up 24%. [SP=161 Cap=154m]
GSTechnologies (GST) £1.33m placing at 2.1p, a 3% discount, to keep the lights on. [SP=2.12 Cap=31m]

In line: GLE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#472262

Postby MrContrarian » January 12th, 2022, 7:56 am

Smallcap Sweep. 12-Jan-22
Reanimating the corpse of corps

Frontier IP (FIPP) guides H1(Dec) ahead of management expectations. CItes increase in Exscientia holding book value. [SP=95 Cap=52m]
Topps Tiles (TPT) recent Q rev: commercial up 21% but retail LFL up 1%. Why quote LFL for one and not the other? No total rev fig. Why do i get the feeling they are finessng the figures? Expects gross margins moderately lower yoy. [SP=64 Cap=125m]
Portmeirion (PMP) guides FY21 rev at least £104m, 10% above market expectations, and pretax £7m, 9^ above. Cites very high demand for our consumer homeware brands around the world, particularly in the US. [SP=623.25 Cap=87m]
Accrol (ACRL) warns again as paper cost surges. Costs will be passed on but margin hit in meantime. Guides FY(Apr) rev up 17% and adj EBITDA £9m, down 42%. Co "continues to operate well within its existing banking covenants and has more than sufficient liquidity to meet its existing and future needs...In light of the above and the short-term but inherent volatility of earnings experienced in the current year, the Board has concluded that it is now appropriate for Accrol to conduct a full strategic review", [SP=31.5 Cap=100m]
IQGeo (IQG) guides FY(Dec) marginally ahead of expectations with rev up 48%, gross margin over 60% and adj EBITDA loss £1m max. [SP=129.6 Cap=75m]
Ten Lifestyle (TENG) wins multi-year contract in the Americas with a new corporate client, one of the world's largest private banks and wealth managers. No $$$. [SP=100.91 Cap=84m]
DFS Furniture (DFS) guides FY(June) pretax in line despite H1 rev down. Order bank c. £200m higher than pre-pandemic level. Plans to return capital despite £65-70m net debt. CF ScS which is hoarding c. £90m net cash. [SP=242 Cap=625m]
InnovaDerma (IDP) guides H1(Dec) rev £3.7m down 10%. Blames "ceasing loss-making sales promotions and reducing marketing investment in lower priority brands such as Nuthing". Gross margin improvements and operational cost reductions remain robust despite input pricing pressure. Outlook "remains optimistic that the transformation plan enacted this year, as well as underlying improved consumer consumption and retail momentum versus last year will enable the business to continue its improvement trajectory with a return to profitability this year remaining the Board's intention". No idea if it's in line. [SP=39.7 Cap=11m]
Equals (EQLS) guides FY(Dec) rev up 52% but profit in line. Q4 rev up 96%. "Without the need for additional investment capital, we are able to grow revenues, profits and cash balances whilst continuing to invest in further product developments. Accordingly, we are extremely excited and confident in the future of the Group." [SP=67 Cap=120m]
Image Scan (IGE) launches ThreatScan-AS1 integrated portable X-Ray system for bomb squads and security professionals. Has an amorphous silicon detector panel. Wooo. [SP=3.19 Cap=4m]
Hostelworld (HSW) FY(Dec) sounds in line. "Consistent recovery in bookings and revenue versus 2019 levels throughout the year, save for the latter part of the year which was impacted by the emergence of the Omicron variant." [SP=69.2 Cap=80m]
Alfa Financial Software (ALFA) guides FY21 towards the upper end of market expectations, which are revenue of £80m - £82m and operating profit of £19m - £22m. [SP=180 Cap=540m]
Winkworth (WINK) guides FY(Dec) rev above mgmt exp and pretax ahead of market forecasts. FY divs will total 17p (6.68p) inc specials. [SP=202 Cap=26m]

In line: EAH, MPAC, CYAN, ABDP, NICL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#472628

Postby MrContrarian » January 13th, 2022, 7:52 am

Smallcap Sweep. 13-Jan-22
The bacon bap of British investing

Xaar (XAR) guides FY(Dec) rev up 23% or 12% organic. Made an adj profit in H2 due to strong revenue growth and cost management actions. In line? [SP=178.6 Cap=140m]
Woodbois (WBI) Guides FY rev up 15%, constrained by lack of containers. Gross profit $3.3m ($1.2m). "Pandemic continues to cause delays and disruption to container availability, port operations and inland logistics with local restrictions, worker shortages, port strikes and overflowing storage facilities leading to complicated handling and congestion." Prices higher though. "We are also looking at ways to fund accelerating our growth and this includes reviewing our interests in Mozambique." [SP=4.26 Cap=79m]
East Imperial (EISB) the 'global purveyor of ultra-premium beverages' makes £3.4m placing at 10.5p, a 9% discount, to fund expansion. Guides FY21 rev up 60% and back to 2019 level. Confident of delivering further progress. Ultra-premium beverages are mixers, not 50 year aged single malts as you might imagine. [SP=11 Cap=34m]
MJ Hudson (MJH) wins multi-year contract to advise the ACCESS local government pension scheme Pool. Worth multi-million £. [SP=38.97 Cap=67m]
React (REAT) 5 yr contract withThe ExtraCare Charitable Trust, Worth £1m+ PA. Hopes to upsell. [SP=1.71 Cap=9m]
Advfn (AFN) housts For Sale sign. Co "has noted several recent announcements of significant shareholdings and the Board is concerned that control may be being sought by long-standing group of shareholders whose total interests may not be aligned with shareholders as a whole." [SP=65.01 Cap=17m]
Rosslyn Data Technologies (RDT) slices FY(Apr) rev guidance to £6.0m+, with ARR to be at least £5.1m and a corresponding impact on EBITDA. Says "larger contracts have lengthy lead times and Covid restrictions that have been experienced across the economy have lengthened these further." [SP=4 Cap=14m]
Mercantile Ports & Logistics (MPL) serial dissapointer does its job and guides FY21 rev below market expectations. "Since the start of the year, the Company has seen some improvement in the trading conditions in the region but, until such time as COVID restrictions are removed, the Company will take a more cautious outlook for the current financial year." [SP=27 Cap=11m]
Quixant (QXT) guides FY(Dec) rev $87.1m, ahead of market expectations of $79m. Adj pretax also ahead of exp of $4.9m. Strong order book. [SP=174.5 Cap=115m]
Science Group (SAG) guides FY21 rev £80m and adj op profit c. £16m up 45%. In line? [SP=450 Cap=205m]
Card Factory (CARD) guides FY(Jan) rev over £360m and pretax £7-10m, both ahead of mgmt exp. [SP=63.5 Cap=217m]
Circassia (CIR) guides FY(Dec) rev up 17% and adj EBITDA c. £0.6m, ahead of market expectations [SP=46.05 Cap=193m]
Finsbury Food (FIF) guides H1(Dec) rev up 9%. Co "has faced persistent pressure from input cost inflation, staff shortages and other supply chain disruptions. It has been able to successfully mitigate the impact of these pressures to date." [SP=99 Cap=129m]
Toople (TOOP) RNSs another presumably tiny contract, for a family office with a network of international advisers. No £££. [SP=0.05 Cap=2m]

In line: ATQT, NBI
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#472969

Postby MrContrarian » January 14th, 2022, 7:43 am

Smallcap Sweep. 14-Jan-22
Morning dump into the toilet of trading

Osirium Technolgies (OSI) guides FY(Dec) rev £1.45m+ (£1.43m). "Whilst average initial contract values have been lower due to the delayed decision making on larger strategic IT projects throughout the pandemic, the Group's significantly increased customer base provides increased up-sell opportunities." [SP=14.1 Cap=4m]
Minds + Machines (MMX) to return £19m via a tender a 10.4p, a 26% premium, for up to 67% of shares. Will delist 21 Feb. [SP=8.13 Cap=22m]
Sensyne Health (SENS) £6.35m loan note from shareholders to keep the lights on while it finds a buyer. Repayable at 25% premium and has warrants at 10p, an 87% discount! Detailed discussions with a few possible buyers. Trading update. [SP=74.25 Cap=122m]
Cornerstone FS (CSFS) guides FY(Dec) rev £2.3m up 38% after very strong H2. Gross margin 51.5% (29.8%). [SP=32.9 Cap=7m]
Foxtons (FOXT) sells D&G lossmaking sales business to its mgmt but keeps letting side. Gets only nominal sum and lets it keep £3.7m cash. £3m impairment. [SP=41.55 Cap=133m]
Bonhill (BONH) warns again, cuts FY(Dec) rev guidance by £0.1m to £16.4m and cust EBITDA to £0.2m from £0.8m. Blames covid causing "unexpected, last-minute reductions in margin for its final events of the year in both the UK and US, as well as reduced bookings".Bookings for FY22 up £1m. [SP=9.22 Cap=9m]
Cineworld (CINE) Dec rev only 12% down in 2019, Oct 44% down. Positive cash flow in Q4. Claims the cinema is still the best place to watch a movie but this bum is staying at home. [SP=38.79 Cap=530m]
Secure Trust Bank (STB) total new business lending up 52% to record £471m. "Run-rate of net loan book growth ahead of recently announced medium term target of 15%+ CAGR." [SP=1342.5 Cap=250m]

In line: QUIZ, SNR, SMRT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#473677

Postby MrContrarian » January 17th, 2022, 7:48 am

Smallcap Sweep. 17-Jan-22
DP Poland delivers unwanted dip

Yourgene Health (YGEN) guides FY(Mar) rev £37m+ and adj EBITDA up £5.5m, both above already upgraded market expectations. [SP=12 Cap=87m]
CentralNic (CNIC) guides FY(Dec) rev c. $410m an adj EBITDA c.$45m, both c.5%above mkt f/c. [SP=129.5 Cap=325m]
Alphawave IP (AWE) guides FY21 bookings $244m up 225%, above mgmt exp. Q4 new bookings $25.5m. [SP=175 Cap=1163m]
CIP Merchant Capital (CIP) responds to mandatory cash offer of 55p. Disdainful but will consider it. [SP=51.25 Cap=29m]
Digital 9 Infrastructure (DGI9) consultation on change to Investment Policy. Wants to increase 20% limit in any single asset to 25%. [SP=109.1 Cap=788m]
Destiny Pharma (DEST) bullish update [SP=106.75 Cap=64m]
Access Intelligence (ACC) guides FY(Nov) rev £33.1m up 73%, adj EBITDA c.£0.5m in line with mgmt exp. Net cash £13m, significantly ahead of mgmt expectation. [SP=152 Cap=195m]
Distil (DIS) Q3 rev down 32%. Co "reflected a significant reduction in domestic market promotional discounting and comparison to an extraordinary year last year due to Covid related lockdowns and unusually high levels of promotion...consumer sales in the UK hospitality sector and export markets began to show signs of recovery". [SP=1.88 Cap=13m]
Hostmore (MORE) guides FY(2 Jan) EBITDA well ahead of the market consensus of £18.6m. Dec rev down 8% on 2019 but ahead of early-month expectations. Trading since 3 January 2022 more in line with expectations. [SP=109.6 Cap=138m]
Inland Homes (INL) application for judicial review of approval of plans for 514 homes at Hillingdon Gardens has been quashed by the High Court. [SP=57.25 Cap=131m]
Iofina (IOF) H1 production in line [SP=18.84 Cap=36m]
Pebble (PEBB) guides FY(Dec) above market expectations.. Rev up 40% and adj EBITDA up 53%. [SP=115 Cap=201m]
DP Poland (DPP) guides FY(Dec) profit below market expectations due to food and wage rises. "The Board is assessing the full impact on profitability for FY21 and the potential impact on the current year." [SP=6 Cap=39m]
M. P. Evans (MPE) production updata. 5p special div. [SP=817.02 Cap=450m]

In line: PIER, WPS, HAT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#473983

Postby MrContrarian » January 18th, 2022, 8:01 am

Smallcap Sweep. 18-Jan-22
Results at the double

Yourgene Health (YGEN) EKF will offer a non-invasive prenatal technology service to the US market based on Yourgene's technology for an initial 5-year period. No £££. [SP=11.75 Cap=85m]
ReNeuron (RENE) throws in the towel on its retinitis pigmentosa work. Will "focus its research and development on its Exosome technology platform, where it currently has seven ongoing collaborations with further potential partnerships in discussion. Concurrently, the Company intends to out-license its RP programme assets following completion of the current clinical data package" [SP=78.8 Cap=45m]
SourceBio (SBI) guides FY(Dec) rev up 82% and adj EBITDA up 70%, significantly ahead of market expectations. Outlook "solid start to trading in the new year and is optimistic in relation to growth opportunities in the Core Divisions. PCR testing volumes have been subject to the pendulum swings in Government policy regarding PCR or Lateral Flow testing requirements for travel. Forecasting volumes for the Infectious Disease Testing business unit remains difficult for 2022". [SP=150.05 Cap=111m]
Guild Esports (GILD) a crypto exchange, Bitstamp, will sponsor co. £1.5m PA for 3 yrs. [SP=3.2 Cap=17m]
Alliance Pharma (APH) guides FY(Dec) U/L pretax comfortably ahead of market expectations. 'See-through revenue' up 23%. Cites outperformance in Kelo-Cote. [SP=102.8 Cap=553m]
Gattaca (GATC) warns FY(Jul) U/L pretax-cont breakeven, significantly below market expectations, due to delayed recovery in contract business. [SP=90 Cap=45m]
Ashtead Technology (AT.) guides FY(Dec) rev up 30%, ahead of guidance. Adj EBITDA modestly ahead and adj EBITA comfortably ahead. [SP=194 Cap=154m]
Capital (CAPD) guides FY(Dec) rev up 68%, slightly ahead of recently revised guidance. The momentum has continued into 2022 across all business units. [SP=88.8 Cap=169m]
Sanderson Design (SDG) guides FY(Jan) rev slightly ahead of mgmt exp (£112m) but adj pretax significantly ahead at £12m+. [SP=153 Cap=109m]
Ten Lifestyle (TENG) wins contract with one of Japan's largest wealth management businesses. " The contract is expected initially to be Small (below £0.25m), with the potential to grow into a Medium contract during the next financial year." [SP=116.06 Cap=97m]
Inland Homes (INL) wins planning appeal for 206 homes on a brownfield site in Staines. [SP=57 Cap=130m]
Eagle Eye Solutions (EYE) wins third US customer. No $$$. [SP=610 Cap=159m]
Carr's (CARR) last 20 weeks period broadly in line with mgmt exp. Engineering traded behind expectations, but significantly ahead of the prior year. "Performance expectations for the full year remain unchanged." [SP=153.5 Cap=144m]
Brickability (BRCK) guides FY(Mar) adj EBITDA at least £32m, ahead of current market expectations. "Demand for the Group's product offering building throughout this year and expected to continue into the new financial year." [SP=99 Cap=296m]
Distribution Finance Capital (DFCH) guides FY(Dec) pretax loss c.£4m (£13.6m). moderately ahead of mgmt expectations. "Whilst manufacturers continue to report an easing of supply chain and shipping issues across many of the sectors in which the Company operates, the Board remains realistic about the Group's near-term loan book growth in light of the on-going challenges caused by COVID-19. Despite this level of uncertainty, the Board is targeting full year profitability for 2022." [SP=47.8 Cap=86m]
Anexo (ANX) guides FY(Dec) rev above exp and pretax significantly ahead of market expectations. Cites strong growth in the motorcycle courier market, the withdrawal of competitors due to Covid and the implementation of the Civil Liability Act. [SP=149 Cap=173m]
Blancco Technology (BLTG) guides H1(Dec) rev above mgmt expectations. Adj operating profit, adj EBITDA and cash expected to be comfortably above mgmt expectations. [SP=222.5 Cap=168m]
Henry Boot (BOOT) guides FY(Dec) pretax materially ahead of market expectations of £30.7m. [SP=284 Cap=379m]

In line: OCTP, CCS, PRES
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#474287

Postby MrContrarian » January 19th, 2022, 7:53 am

Smallcap Sweep. 19-Jan-22
Racking news till the spine splits

Boku (BOKU) guides FY(Dec) rev up 22% and adj EBITDA up 31%. In line? FX moves cut result. Sells Boku Identity for $32.2m to focus resources on the Payments business. [SP=170 Cap=504m]
Mode Global (MODE) CEO scarpers with immediate effect. He is thaked. [SP=19 Cap=17m]
Omega Diagnostics (ODX) CEO scarpers with immediate effect. He is thanked. Co says no short term need for capital as it has £2.5m cash and an undrawn overdraft facility of £2m. "Like all growth companies, Omega will look to raise funds to drive growth as and when appropriate." Shame the CEO won't be there to see this growth. [SP=15.49 Cap=28m]
East Imperial (EISB) gets distributor for 8 US states for its 'ultra-premium' mixers, [SP=10.8 Cap=33m]
Science in Sport (SIS) guides FY(Dec) rev up 25% and U/L EBITDA £2.2m up 100%, ahead of expectations (whose?). [SP=70 Cap=95m]
Centaur Media (CAU) guides FY(Dec) rev at least £38.5m and adj EBITDA margin over 15%, both ahead of consensus. [SP=54.68 Cap=82m]
CPP (CPP) guides FY(Dec) broadly in line with market expectations with rev (cont) up 5% and EBITDA (cont) up 29%. EBITDA rise mainly down to release of a third-party commission. Expects FY22 rev broadly in line with market expectations but unfavourable economic and currency situation in Turkey is expected to limit both margin and EBITDA growth. [SP=360 Cap=32m]
Argo Blockchain (ARB) something about Argo Labs, "its in-house innovation arm established to identify opportunities within the disruptive and innovative sectors of the cryptocurrency ecosystem". [SP=82 Cap=384m]
ASA International (ASAI) the usual all-detail and no overview update. Cautions "While the Company's operational performance appears to gradually normalize in most countries except for India and Myanmar, the risk of additional challenges to our operations should not be underestimated." [SP=132 Cap=132m]
PCI-PAL (PCIP) strong H1(Dec) means that FY rev and loss will beat mkt exp. "Proceedings in relation to the alleged patent infringement being made against the Company are ongoing and the Company is continuing to work towards an outcome that it believes will best benefit the business." [SP=57.25 Cap=37m]
Midwich (MIDW) guides FY(Dec) rev up 20% and adj pretax £31.5+, ahead of previous expectations (whose?). [SP=626 Cap=555m]
Devro (DVO) guides FY(Dec) constant currency rev up 5% and EPS modestly ahead of mkt expectations (16.9p) due one-off tax benefit from change in the UK corporate tax rate. [SP=202 Cap=337m]
Christie (CTG) guides FY(Dec) op profit very significantly in excess of market expectations. Cites extremely strong YE for Business Broking, Valuation & Advisory practice. [SP=100.03 Cap=27m]
Stelrad (SRAD) guides FY(Dec) EBITDA slightly ahead of mgmt exp despite rising steel prices. [SP=212.2 Cap=270m]
Avation (AVAP) says H1(Dec) "will demonstrate certain improvements, albeit remain a loss". [SP=91.71 Cap=64m]

In line: NAH, ITS, GFRD, TMG, APP
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#474636

Postby MrContrarian » January 20th, 2022, 8:11 am

Smallcap Sweep. 20-Jan-22
A record 26 companies today

Pennant International (PEN) guides FY(Dec) rev £16m and loss before interest, taxation and amortisation c. £0.6m, worse than mgmt exp. Blames a contract delay and further slippage in the MTE programme. [SP=32 Cap=12m]
Silverbullet (SBDS) £425k of contract wins. [SP=235 Cap=32m]
IXICO (IXI) a client says it will close its open-label extension study in Huntington's disease in May. £0.3m rev hit. [SP=52.5 Cap=25m]
Parity (PTY) guides FY(Dec) rev slightly ahead of £47.6m mkt exp, net fee income £4.1m in line. Modest adj EBITDA profit, instead of an expected small loss. [SP=7.25 Cap=7m]
Good Energy (GOOD) sells renewable generation portfolio for up to £24.5m inc £8.1m contingent. NA was £17.7m. Money "will be used to accelerate and support further investments across both transport and decentralised energy to deliver Good Energy's strategic plan". [SP=233 Cap=39m]
PensionBee (PBEE) guides FY(Dec) rev £13m up 103%, ahead of guidance. Core KPIs in line. Guides FY22 rev £20m and adj EBITDAM positive. M = management fees? Why exclude that? [SP=133.8 Cap=297m]
Netcall (NET) H1(Dec) comfortably in line with management expectations. [SP=69.34 Cap=104m]
GetBusy (GETB) guides FY(Dec) rev slightly ahead of market expectations of £15.1m. ARR up 13% at const currency. Adj loss in line (£1.2m). [SP=70.03 Cap=35m]
NewRiver (NRR) Q3. Trading in line to to deliver its 10% total accounting return target. [SP=98.9 Cap=305m]
N Brown (BWNG) guides FY(Mar) adj EBITDA £93m and £96m, at the lower end of guided range. Blames "online market conditions and a slightly higher level of project spend now being expensed rather than capitalised. " [SP=39.62 Cap=182m]
Artisanal Spirits Company (ART) guides FY(Dec) rev c. £18m, comfortably ahead of market expectations, with both UK and international sales growing by c. 20%. [SP=95 Cap=66m]
Wincanton (WIN) guides FY profit above market expectations after strong Q3. [SP=372 Cap=465m]
Zenova (ZED) becomes trusted partner for Epsom & St. Hellier University Hospitals NHS Trust. "It paves the way for Zenova's products to be used to improve fire safety and insulation throughout the Trust's estate." [SP=18.95 Cap=NA]
Brave Bison (BBSN) guides FY(Dec) market forecasts. Rev up 47%+, pretax £0.4m+ (-£2.3m). [SP=1.94 Cap=21m]
Epwin (EPWN) guides FY(Dec) rev up c. 37% and adj pretax modestly ahead of mkt expectations of £12.8m. [SP=108 Cap=157m]

In line: AREC, CPC, GYM, LUCE, RBG, AVG, G4M, KIE, KOO, SNWS, APTD
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#474920

Postby MrContrarian » January 21st, 2022, 7:29 am

Smallcap Sweep. 21-Jan-22
Good show from Everyman

Photo-Me International (PHTM) an Independent Committee will consider the 75p( 1% discount) mandatory offer. [SP=75.6 Cap=286m]
OnTheMarket (OTMP) guides FY(Jan) rev slightly ahead of market consensus. Adj op profit £2.5m+. [SP=116.6 Cap=87m]
Arden (ARDN) re takeover - FCA approves the change of control [SP=19.15 Cap=6m]
M&C Saatchi (SAA) FCA closes investigation with no action. Guides FY(Dec) materially ahead mgmt expectations. [SP=176 Cap=215m]
X5 Retail (FIVE) guides FY21 rev up 11% in RUB and EBITDA margins to be at least at the level of 2020. [SP=NA Cap=NA]
Westminster (WSG) Standstill Period on $1.7m airport contract has now ended and the formal notice of contract issued. [SP=3.4 Cap=11m]
Restaurant Group (RTN) guides FY21 adj EBITDA at the top end of of guided £73m-£79m. Net debt less than £180m. Cites cost control and continued strong trading. [SP=97.85 Cap=749m]
Eurocell (ECEL) guides FY(Dec) pretax slightly ahead of market expectations of £26.5m. [SP=259.7 Cap=291m]
Everyman Media (EMAN) guides FY(Dec) rev up 101%, and 25% down on 2019. Guides EBITDA ahead of current market forecast at c. £8.3m due to strong Dec. [SP=135 Cap=123m]

In line: CCT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

Bouleversee
Lemon Quarter
Posts: 4652
Joined: November 8th, 2016, 5:01 pm
Has thanked: 1195 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Jan 2022

#475047

Postby Bouleversee » January 21st, 2022, 1:14 pm

Photo-Me Mandatory Takeover Offer -

I have to say that in all my years of investment I have never received two such extraordinary RNS announcements. I am surprised that this can be legal.
Does anyone else hold this company and have any views? Needless to say, I am losing money on this investment.

RNS: 2117Z and 2118Z

dealtn
Lemon Half
Posts: 6072
Joined: November 21st, 2016, 4:26 pm
Has thanked: 441 times
Been thanked: 2324 times

Re: MrC's Smallcap Sweeps for Jan 2022

#475516

Postby dealtn » January 23rd, 2022, 11:12 am

Bouleversee wrote:Photo-Me Mandatory Takeover Offer -

I have to say that in all my years of investment I have never received two such extraordinary RNS announcements. I am surprised that this can be legal.
Does anyone else hold this company and have any views? Needless to say, I am losing money on this investment.

RNS: 2117Z and 2118Z


What specifically do you see as being questionably legal? The RNS 2117Z is specifically following the law, as is the mandatory cash offer. (It is mandatory to make the offer under law, it isn't mandatory to accept it).

The fact you are losing money on the investment is irrelevant to this process, and reflects your purchase price, not the offer price which is at close to a 23 month high.

I don't own, nor have I ever.

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Jan 2022

#475660

Postby MrContrarian » January 24th, 2022, 7:51 am

Smallcap Sweep. 24-Jan-22
Newsy musings

M&C Saatchi (SAA) AdvancedAdvT offers better merger terms: 2.245 shares or 1.633 + 40p. [SP=175 Cap=214m]
Corero Network Security (CNS) adds a FY21 pretax range of $1.2-1.6m to its EBITDA guidance of 22 Dec. [SP=11.2 Cap=58m]
Creo Medical (CREO) non-binding heads of terms with a number of parties for SpydrBlade, Cool Plasma and MicroBlate technologies. It's "a key milestone in achieving its stated goal of licensing its technology to established, multi-national partners". [SP=125 Cap=225m]
Belluscura (BELL) demand for, and delivery of, the X-PLO2R portable oxygen concentrator is above Nov guidance. Manufacturing capability has been scaled up significantly. [SP=137.46 Cap=157m]
GYG (GYG) refit work restarts at bankrupt Nobiskrug Shipyard. Gets €2m of owed money. "Constructive negotiations continue regarding recommencing works on the two New Build projects." [SP=41.67 Cap=20m]
MyHealthChecked (MHC) hikes FY21 guidance. Rev £16.3m and adj EBITDA £2.5m+. The introduction of the verification service provided with MHC's' LFT service has created an increased demand. [SP=1.92 Cap=16m]
Spectra Systems (SPSY) gets additional order for covert materials from its largest central bank customer, adding 20%. The bank also renewed its sensor service contract at nearly double its historical annual value. Plus $500k 10 yr contract with an existing USA state lottery customer. Total ups FY22 rev by $700k. [SP=150.27 Cap=68m]
Big Technologies (BIG) FY(Dec) rev £36.5m+ and adj EBITDA slightly ahead of market expectations1 of c.£20.2m. [SP=311 Cap=887m]
Croma Security Solutions (CSSG) partnership with FinGo, a biometric identity authentication and payments platform. It "will complement and strengthen each company's leading solutions in the provision of non-invasive biometric technology". [SP=85.27 Cap=13m]
De La Rue (DLAR) warns FY(Mar) adj profit only £36-40m vs F/C £45-47m. Blames supply chain shortages, higher costs and staff absence due to covid. [SP=150 Cap=293m]
Mirriad Advertising (MIRI) guides FY(Dec) rev c. £2m. In line? US rev up 180% to c. £884k [SP=22.48 Cap=60m]
Touchstar (TST) guides FY(Dec) pretax up over 200%, EBITDA up over 20%, above market expectations. "Rate of growth in revenue and EBITDA will accelerate in 2022." [SP=75.5 Cap=7m]

In line: GMS, SAAS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

Hallucigenia
Lemon Quarter
Posts: 2614
Joined: November 5th, 2016, 3:03 am
Has thanked: 165 times
Been thanked: 1717 times

Re: MrC's Smallcap Sweeps for Jan 2022

#475751

Postby Hallucigenia » January 24th, 2022, 1:55 pm

Bouleversee wrote:Photo-Me Mandatory Takeover Offer -

I have to say that in all my years of investment I have never received two such extraordinary RNS announcements. I am surprised that this can be legal.
Does anyone else hold this company and have any views? Needless to say, I am losing money on this investment.


If someone acquires more than 30% of a company, they must make an offer for the rest of the shares, at a price at least as high as they've bought at in the last 12 months. As the RNS says, they have to do this under Rule 9 of the Takeover Code.

The idea is to try and be "fair" to other shareholders, who may not want to own a company with such a big controlling interest, and to ensure that they are offered the chance to get out at a "fair" price rather than the buyer favouring some shareholders over others.

It is mandatory to make an offer if the situation requires it, but you do not have to accept (unless they go over 90% of the equity).

Them's the rules of the game - you should be aware of them before playing the game.

Usual procedure is to wait and see, but usually in these circumstances if the offer price isn't stupid then big shareholders usually accept and frankly once they're over 50% then you don't really want to own a company with one controlling owner - and once over 90% you have to accept the offer.

Bouleversee
Lemon Quarter
Posts: 4652
Joined: November 8th, 2016, 5:01 pm
Has thanked: 1195 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Jan 2022

#475784

Postby Bouleversee » January 24th, 2022, 3:36 pm

Hallucigenia wrote:
Bouleversee wrote:Photo-Me Mandatory Takeover Offer -

I have to say that in all my years of investment I have never received two such extraordinary RNS announcements. I am surprised that this can be legal.
Does anyone else hold this company and have any views? Needless to say, I am losing money on this investment.


If someone acquires more than 30% of a company, they must make an offer for the rest of the shares, at a price at least as high as they've bought at in the last 12 months. As the RNS says, they have to do this under Rule 9 of the Takeover Code.

The idea is to try and be "fair" to other shareholders, who may not want to own a company with such a big controlling interest, and to ensure that they are offered the chance to get out at a "fair" price rather than the buyer favouring some shareholders over others.

It is mandatory to make an offer if the situation requires it, but you do not have to accept (unless they go over 90% of the equity).

Them's the rules of the game - you should be aware of them before playing the game.

Usual procedure is to wait and see, but usually in these circumstances if the offer price isn't stupid then big shareholders usually accept and frankly once they're over 50% then you don't really want to own a company with one controlling owner - and once over 90% you have to accept the offer.


I was aware of the 30% rule but in my previous experience of such situations, the predator has been an outsider not the CEO presiding over the drop in prices and opportunistically taking advantage of a situation such as Covid to take the company private. I am obviously too naive and/or too principled for the cut-throat business of equity investment. This situation reminds me that I must check up on what is happening at Quarto where I thought someone had crossed the 30% barrier some weeks ago but that had not precipitated an offer. I have been too preoccupied with more important matters to look into it. I must also check what the Photo-Me CEO and his colleagues have been paying themselves while planning this coup and doing nothing for their shareholders. Enough to mop up sufficient shares for the purpose, apparently.

I am not the only one who has been hanging on to Photo-Me shares in the hope/expectation they would recover once Covid 19 had stopped wrecking our lives. I see that there are some very reputable names among the organisations who are having to declare substantial interests, though I suppose they might have bought them recently. It will be interesting to see how they all react to the offer. I shall do nothing in a hurry.
It

Hallucigenia
Lemon Quarter
Posts: 2614
Joined: November 5th, 2016, 3:03 am
Has thanked: 165 times
Been thanked: 1717 times

Re: MrC's Smallcap Sweeps for Jan 2022

#475840

Postby Hallucigenia » January 24th, 2022, 7:31 pm

Bouleversee wrote:I was aware of the 30% rule but in my previous experience of such situations, the predator has been an outsider not the CEO presiding over the drop in prices and opportunistically taking advantage of a situation such as Covid to take the company private.


Business is all about taking opportunities. And just generally, we're going to see more public-to-private deals as there's lots of money sloshing round private equity and valuations of some public companies have been hit due to Covid. And who better to know the value of a company than its own management? As a recent high-profile example, see the Rothermere family taking the Daily Mail private.

Bouleversee wrote:I must check up on what is happening at Quarto where I thought someone had crossed the 30% barrier some weeks ago but that had not precipitated an offer.


The Takeover Code only applies to UK-domiciled companies, but the Quarto holding company is based in the US so (in this case) Delaware law applies.


Return to “Stocks and Share Dealing Discussions”

Who is online

Users browsing this forum: No registered users and 13 guests